Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVL
1076
DELISTED
Nuvalent
NUVL
| $87.5M | 0.01% |
855,610
+73,429
| +9% | +$6.09M |
|
1077
Ultragenyx Pharmaceutical
RARE
$2.55B
| $87.3M | 0.01% |
1,571,081
+65,623
| +4% | +$3.34M |
|
1078
Bank OZK
OZK
$5.61B
| $87M | 0.01% |
2,022,979
+126,352
| +7% | +$5.38M |
|
1079
BridgeBio Pharma
BBIO
$16.5B
| $86.9M | 0.01% |
3,413,949
+123,540
| +4% | +$3.24M |
|
1080
Vontier
VNT
$4.74B
| $86.8M | 0.01% |
2,571,207
+18,091
| +0.7% | +$643K |
|
1081
Five Below
FIVE
$13.5B
| $86.6M | 0.01% |
979,489
+11,504
| +1% | +$969K |
|
1082
Neogen
NEOG
$2.5B
| $86.6M | 0.01% |
5,148,388
+20,387
| +0.4% | +$336K |
|
1083
Denali Therapeutics
DNLI
$3.97B
| $86.1M | 0.01% |
2,955,477
-27,061
| -0.9% | -$671K |
|
1084
Madrigal Pharmaceuticals
MDGL
$11.8B
| $86.1M | 0.01% |
405,655
+5,801
| +1% | +$1.48M |
|
1085
Biohaven
BHVN
$2.21B
| $85.7M | 0.01% |
1,714,612
+44,174
| +3% | +$1.72M |
|
1086
Wayfair
W
$14.6B
| $85.7M | 0.01% |
1,524,854
+35,268
| +2% | +$1.7M |
|
1087
Western Union
WU
$2.21B
| $85.7M | 0.01% |
7,179,698
+25,458
| +0.4% | +$307K |
|
1088
Apple Hospitality REIT
APLE
$3.82B
| $85.6M | 0.01% |
5,761,364
+62,149
| +1% | +$899K |
|
1089
RXO
RXO
$3.58B
| $85.6M | 0.01% |
3,055,229
+441,994
| +17% | +$12.5M |
|
1090
AST SpaceMobile
ASTS
$21.5B
| $85.4M | 0.01% |
3,267,066
+281,749
| +9% | +$6.35M |
|
|
HCP
1091
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $85.4M | 0.01% |
2,522,002
+385,118
| +18% | +$13M |
|
1092
Avnet
AVT
$7.92B
| $85.4M | 0.01% |
1,566,832
-45,632
| -3% | -$2.4M |
|
1093
Rush Enterprises Class A
RUSHA
$6.22B
| $85.4M | 0.01% |
1,616,048
+16,803
| +1% | +$833K |
|
1094
Insperity
NSP
$2.01B
| $85.3M | 0.01% |
968,634
+138,837
| +17% | +$12.9M |
|
|
SEM
1095
DELISTED
Select Medical
SEM
| $85.2M | 0.01% |
4,532,948
+87,010
| +2% | +$1.67M |
|
|
CIVI
1096
DELISTED
Civitas Resources
CIVI
| $84.9M | 0.01% |
1,675,903
+53,888
| +3% | +$3.34M |
|
1097
Cedar Fair
FUN
$1.67B
| $84.8M | 0.01% |
+2,102,280
| New | +$96.2M |
|
1098
Valaris
VAL
$5.47B
| $84.7M | 0.01% |
1,519,644
+66,229
| +5% | +$4.34M |
|
1099
Hexcel
HXL
$7.82B
| $84.6M | 0.01% |
1,367,433
-7,728
| -0.6% | -$486K |
|
1100
Terex
TEX
$7.74B
| $84.5M | 0.01% |
1,596,070
+8,624
| +0.5% | +$477K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.